Urinary biomarkers as point-of-care tests for predicting progressive deterioration of kidney function in congenital anomalies of kidney and urinary tract: trefoil family factors (TFFs) as the emerging biomarkers.
Congenital anomalies of kidney and urinary tract (CAKUT)
Microalbuminuria
Neutrophil gelatinase-associated lipocalin (NGAL)
Progressive functional deterioration
Trefoil family factor (TFF)
Urinary biomarker
Journal
Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
23
07
2020
accepted:
22
10
2020
revised:
02
10
2020
pubmed:
10
1
2021
medline:
15
2
2022
entrez:
9
1
2021
Statut:
ppublish
Résumé
Children with congenital anomalies of kidney and urinary tract (CAKUT) are at high risk of progressive deterioration of kidney function and further developing stage 5 chronic kidney disease (CKD 5), even after a successful surgery. This prospective study was designed to determine whether urinary biomarkers can predict progressive deterioration of kidney function in children with CAKUT. The study included 50 consecutive children, aged < 14 years, who were diagnosed with congenital uropathies (PUV, VUR, and PUJO) and 20 age-matched controls. Examination of four urinary biomarkers, i.e., trefoil family factors (TFF) 1 and 3, neutrophil gelatinase-associated lipocalin (NGAL) and microalbuminuria (MALB) was done at the beginning of follow-up. Kidney function was assessed, at the beginning and after 12-months of follow-up, by technetium-99m diethylene triamine pentaacetic acid (DTPA) and technetium-99m dimercaptosuccinic acid (DMSA) scans. Progressive deterioration in the kidney function was defined as a fall in the GFR from ≥ 60 to < 60 ml/min/1.73 m The median (IQR) age of children with CAKUT and controls was 3 (1.5-5) and 2.3 (1.2-3.6) years, respectively, and showed no significant difference (p = 0.29). Median concentrations of TFF1, TFF3, NGAL, and microalbumin in patients were 44.5, 176.5, 281.2, and 15.5 mcg/gCr, respectively, and were significantly elevated as compared to controls (p < 0.05). Children belonging to group 2 had significantly higher concentration of biomarkers as compared to those in group 1. TFF3 was found have the highest AUC (0.9198) on ROC curve for predicting progressive functional deterioration. Urinary TFFs, NGAL, and microalbumin significantly correlate with progressive deterioration of kidney function in children harboring CAKUT. TFF3, with the strongest prediction of functional deterioration, is an emerging peptide showing sufficient potential to be included in the biomarker panel. Graphical abstract.
Sections du résumé
BACKGROUND
Children with congenital anomalies of kidney and urinary tract (CAKUT) are at high risk of progressive deterioration of kidney function and further developing stage 5 chronic kidney disease (CKD 5), even after a successful surgery. This prospective study was designed to determine whether urinary biomarkers can predict progressive deterioration of kidney function in children with CAKUT.
METHODS
The study included 50 consecutive children, aged < 14 years, who were diagnosed with congenital uropathies (PUV, VUR, and PUJO) and 20 age-matched controls. Examination of four urinary biomarkers, i.e., trefoil family factors (TFF) 1 and 3, neutrophil gelatinase-associated lipocalin (NGAL) and microalbuminuria (MALB) was done at the beginning of follow-up. Kidney function was assessed, at the beginning and after 12-months of follow-up, by technetium-99m diethylene triamine pentaacetic acid (DTPA) and technetium-99m dimercaptosuccinic acid (DMSA) scans. Progressive deterioration in the kidney function was defined as a fall in the GFR from ≥ 60 to < 60 ml/min/1.73 m
RESULTS
The median (IQR) age of children with CAKUT and controls was 3 (1.5-5) and 2.3 (1.2-3.6) years, respectively, and showed no significant difference (p = 0.29). Median concentrations of TFF1, TFF3, NGAL, and microalbumin in patients were 44.5, 176.5, 281.2, and 15.5 mcg/gCr, respectively, and were significantly elevated as compared to controls (p < 0.05). Children belonging to group 2 had significantly higher concentration of biomarkers as compared to those in group 1. TFF3 was found have the highest AUC (0.9198) on ROC curve for predicting progressive functional deterioration.
CONCLUSION
Urinary TFFs, NGAL, and microalbumin significantly correlate with progressive deterioration of kidney function in children harboring CAKUT. TFF3, with the strongest prediction of functional deterioration, is an emerging peptide showing sufficient potential to be included in the biomarker panel. Graphical abstract.
Identifiants
pubmed: 33420628
doi: 10.1007/s00467-020-04841-8
pii: 10.1007/s00467-020-04841-8
doi:
Substances chimiques
Biomarkers
0
Lipocalin-2
0
Trefoil Factors
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1465-1472Références
Murugapoopathy V, Gupta IR (2020) A primer on congenital anomalies of the kidneys and urinary tracts. Clin J Am Soc Nephrol 15:723–731
doi: 10.2215/CJN.12581019
Toka HR, Toka O, Hariri A, Nguyen HT (2010) Congenital anomalies of kidney and urinary tract. Semin Nephrol 30:374–386
doi: 10.1016/j.semnephrol.2010.06.004
Wühl E, van Stralen KJ, Verrina E, Bjerre A, Wanner C, Heaf JG, Zurriaga O, Hoitsma A, Niaudet P, Palsson R, Ravani P, Jager KJ, Schaefer F (2013) Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract. Clin J Am Soc Nephrol 8:67–74
doi: 10.2215/CJN.03310412
Mandelia A, Bajpai M, Agarwala S, Gupta AK, Kumar R, Ali A (2013) The role of urinary TGF-β
doi: 10.1007/s00467-013-2506-8
Rinnert M, Hinz M, Buhtz P, Reiher F, Lessel W, Hoffmann W (2010) Synthesis and localization of trefoil factor family (TFF) peptides in the human urinary tract and TFF2 excretion into the urine. Cell Tissue Res 339:639–647
doi: 10.1007/s00441-009-0913-8
Busch M, Dünker N (2015) Trefoil factor family peptides--friends or foes? Biomol Concepts 6:343–359
doi: 10.1515/bmc-2015-0020
Du TY, Luo HM, Qin HC, Wang F, Wang Q, Xiang Y, Zhang Y (2013) Circulating serum trefoil factor 3 (TFF3) is dramatically increased in chronic kidney disease. PLoS One 8:e80271
doi: 10.1371/journal.pone.0080271
Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A, Buemi M (2008) Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis 52:595–605
doi: 10.1053/j.ajkd.2008.01.020
Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, Fong HEH, Cheung CC, Mak TW (2006) Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A 103:1834–1839
doi: 10.1073/pnas.0510847103
Forster CS, Devarajan P (2017) Neutrophil gelatinase-associated lipocalin: utility in urologic conditions. Pediatr Nephrol 32:377–381
doi: 10.1007/s00467-016-3540-0
Kovacevic L, Lu H, Kovacevic N, Thomas R, Lakshmanan Y (2020) Cystatin C, Neutrophil gelatinase-associated lipocalin, and lysozyme C: urinary biomarkers for detection of early kidney dysfunction in children with urolithiasis. Urology 143:221–226
doi: 10.1016/j.urology.2020.05.050
Nishida M, Kawakatsu H, Okumura Y, Hamaoka K (2010) Serum and urinary neutrophil gelatinase-associated lipocalin levels in children with chronic renal diseases. Pediatr Int 52:563–568
doi: 10.1111/j.1442-200X.2010.03067.x
Jagadesan I, Agarwal I, Chaturvedi S, Jose A, Sahni RD, Fleming JJ (2019) Urinary neutrophil gelatinase associated lipocalin - a sensitive marker for urinary tract infection in children. Indian J Nephrol 29:340–344
doi: 10.4103/ijn.IJN_276_18
Abbasi A, Nabizadeh F, Gardeh M, Mohamed Ali K, Yousefifard M, Hosseini M (2020) Discriminatory precision of neutrophil gelatinase-associated lipocalin in detection of urinary tract infection in children: a systematic review and meta-analysis. Arch Acad Emerg Med 8:e56
pubmed: 32440667
pmcid: 7212073
Kim BH, Yu N, Kim HR, Yun KW, Lim IS, Kim TH, Lee MK (2014) Evaluation of the optimal neutrophil gelatinase-associated lipocalin value as a screening biomarker for urinary tract infections in children. Ann Lab Med 34:354–359
doi: 10.3343/alm.2014.34.5.354
Toto RD (2004) Microalbuminuria: definition, detection, and clinical significance. J Clin Hypertens 6:2–7
doi: 10.1111/j.1524-6175.2004.4064.x
Li ZY, Chen YM, Qiu LQ, Chen DQ, Hu CG, Xu JY, Zhang XH (2019) Prevalence, types, and malformations in congenital anomalies of the kidney and urinary tract in newborns: a retrospective hospital-based study. Ital J Pediatr 45:50
doi: 10.1186/s13052-019-0635-9
Kumar BH, Krishnamurthy S, Chandrasekaran V, Jindal B, Ananthakrishnan R (2019) Clinical spectrum of congenital anomalies of kidney and urinary tract in children. Indian Pediatr 56:566–570
doi: 10.1007/s13312-019-1556-9
Soliman NA, Ali RI, Ghobrial EE, Habib EI, Ziada AM (2015) Pattern of clinical presentation of congenital anomalies of the kidney and urinary tract among infants and children. Nephrology (Carlton) 20:413–418
doi: 10.1111/nep.12414
Miao Q, Shen Q, Xu H, Sun L, Tang X, Fang X, Liu H, Zhai Y, Bi Y, Wang X, Chen H (2015) Etiological analysis of 264 cases with chronic kidney disease stage 2 to 5 in children. Zhonghua Er Ke Za Zhi 53:665–669
pubmed: 26757966
Greenberg JH, Kakajiwala A, Parikh CR, Furth S (2018) Emerging biomarkers of chronic kidney disease in children. Pediatr Nephrol 33:925–933
doi: 10.1007/s00467-017-3701-9
Yamanari T, Sugiyama H, Tanaka K, Morinaga H, Kitagawa M, Onishi A, Ogawa-Akiyama A, Kano Y, Mise K, Ohmoto Y, Shikata K, Wada J (2018) Urine trefoil factors as prognostic biomarkers in chronic kidney disease. Biomed Res Int 2018:3024698
doi: 10.1155/2018/3024698
Lebherz-Eichinger D, Tudor B, Ankersmit HJ, Reiter T, Haas M, Roth-Walter F, Krenn CG, Roth GA (2015) Trefoil factor 1 excretion is increased in early stages of chronic kidney disease. PLoS One 10:e0138312
doi: 10.1371/journal.pone.0138312
Alvarez MC, Fernandes J, Michel V, Touati E, Ribeiro ML (2018) Effect of Helicobacter pylori Infection on GATA-5 and TFF1 regulation, comparison between pediatric and adult patients. Dig Dis Sci 63:2889–2897
doi: 10.1007/s10620-018-5223-0
Verey F, Nexo E, Greenwood R, Berry M, Corfield AP (2011) Trefoil factor family peptides are increased in the saliva of children with mucositis. Clin Chem Lab Med 49:2051–2055
doi: 10.1515/CCLM.2011.667
Heitkemper MM, Cain KC, Shulman RJ, Burr RL, Ko C, Hollister EB, Callen N, Zia J, Han CJ, Jarrett ME (2018) Stool and urine trefoil factor 3 levels: associations with symptoms, intestinal permeability, and microbial diversity in irritable bowel syndrome. Benef Microbes 2018:345–355
doi: 10.3920/BM2017.0059
Busch M, Metz K, Beier M, Biewald E, Dünker N (2018) Trefoil factor family 1 expression correlates with clinical outcome in patients with retinoblastoma. Retina 38:2422–2428
doi: 10.1097/IAE.0000000000001881
Bajpai M, Pal K, Bal CS, Gupta AK, Pandey RM (2003) Role of plasma renin activity in the management of primary vesicoureteric reflux: a preliminary report. Kidney Int 64:1643–1647
doi: 10.1046/j.1523-1755.2003.00278.x
Bajpai M, Bal CS, Tripathi M, Kalaivani M, Gupta AK (2007) Prenatally diagnosed unilateral hydronephrosis: prognostic significance of plasma renin activity. J Urol 178:2580–2584
doi: 10.1016/j.juro.2007.08.058
Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RA, Thaiss F (2002) Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. Kidney Int 61:1986–1995
doi: 10.1046/j.1523-1755.2002.00365.x
Baus-Loncar M, Al-azzeh ED, Romanska H, el Lalani N, Stamp GW, Blin N, Kayademir T (2004) Transcriptional control of TFF3 (intestinal trefoil factor) via promoter binding sites for the nuclear factor kappaB and C/EBPbeta. Peptides 25:849–854
doi: 10.1016/j.peptides.2003.11.019
Wasilewska A, Taranta-Janusz K, Dębek W, Zoch-Zwierz W, Kuroczycka-Saniutycz E (2011) KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol 26:579–586
doi: 10.1007/s00467-011-1773-5
Parmaksız G, Noyan A, Dursun H, İnce E, Anarat R, Cengiz N (2016) Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP. Pediatr Nephrol 31:97–103
doi: 10.1007/s00467-015-3194-3
Nickavar A, Valavi E, Safaeian B, Moosavian M (2020) Validity of urine neutrophile gelatinase-associated lipocalin in children with primary vesicoureteral reflux. Int Urol Nephrol 52:599–602
doi: 10.1007/s11255-019-02355-3
Kostic D, Dos Santos Beozzo GPN, do Couto SB, Kato AHT, Lima L, Palmeira P, Krebs VLJ, Bunduki V, Francisco RPV, Zugaib M, de Carvalho WB, Koch VHK (2019) First-year profile of biomarkers for early detection of renal injury in infants with congenital urinary tract obstruction. Pediatr Nephrol 34:1117–1128
doi: 10.1007/s00467-019-4195-4
Saito H, Tanaka T, Tanaka S, Higashijima Y, Yamaguchi J, Sugahara M, Ito M, Uchida L, Hasegawa S, Wakashima T, Fukui K, Nangaku M (2018) Persistent expression of neutrophil gelatinase-associated lipocalin and M2 macrophage markers and chronic fibrosis after acute kidney injury. Physiol Rep 6:e13707
doi: 10.14814/phy2.13707
Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, Cullere X, Eckfeldt JH, Doria A, Mayadas TN, Warram JH, Krolewski AS (2012) Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol 23:507–515
doi: 10.1681/ASN.2011060627